NATCO Pharma discloses postal ballot voting results under Regulation 44 of SEBI LODR, 2015 for four special resolutions.
All four resolutions to re-appoint key executive directors effective April 1, 2026, passed with over 98% votes in favour.
Total votes polled stood at ~11.13 crore shares (62.16–62.17% of total), with e-voting conducted via NSDL platform.
Scrutinizer CS Kiran Kumar Bodla of M/s. BK & Associates confirmed all resolutions passed with requisite majority.